HomeCompareSPNE vs PLD

SPNE vs PLD: Dividend Comparison 2026

SPNE yields 20.96% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.43M in total portfolio value· pulled ahead in Year 6
10 years
SPNE
SPNE
● Live price
20.96%
Share price
$9.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.5K
Annual income
$7,459.80
Full SPNE calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — SPNE vs PLD

📍 PLD pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPNEPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPNE + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPNE pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPNE
Annual income on $10K today (after 15% tax)
$1,781.97/yr
After 10yr DRIP, annual income (after tax)
$6,340.83/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,461,629.92/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPNE + PLD for your $10,000?

SPNE: 50%PLD: 50%
100% PLD50/50100% SPNE
Portfolio after 10yr
$3.29M
Annual income
$2,631,947.99/yr
Blended yield
79.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

SPNE
Analyst Ratings
9
Buy
1
Hold
Consensus: Buy
Price Target
$9.38
-1.7% upside vs current
Range: $6.75 — $12.00
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPNE buys
0
PLD buys
0
No recent congressional trades found for SPNE or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPNEPLD
Forward yield20.96%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$77.5K$6.50M
Annual income after 10y$7,459.80$5,256,436.18
Total dividends collected$45.1K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy
Analyst price target$9.38$136.00

Year-by-year: SPNE vs PLD ($10,000, DRIP)

YearSPNE PortfolioSPNE Income/yrPLD PortfolioPLD Income/yrGap
1$12,796$2,096.44$11,255$555.24+$1.5KSPNE
2$16,199$2,507.19$13,062$1,018.59+$3.1KSPNE
3$20,300$2,966.28$15,903$1,926.67+$4.4KSPNE
4$25,194$3,473.91$20,839$3,823.32+$4.4KSPNE
5$30,988$4,029.51$30,464$8,166.08+$524.00SPNE
6← crossover$37,789$4,631.81$52,054$19,457.30$14.3KPLD
7$45,713$5,278.85$109,886$54,188.93$64.2KPLD
8$54,881$5,968.03$304,030$186,451.18$249.1KPLD
9$65,418$6,696.22$1,166,125$840,813.32$1.10MPLD
10$77,457$7,459.80$6,504,190$5,256,436.18$6.43MPLD

SPNE vs PLD: Complete Analysis 2026

SPNEStock

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Full SPNE Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this SPNE vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPNE vs SCHDSPNE vs JEPISPNE vs OSPNE vs KOSPNE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.